Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05449392 · ClinicalTrials.gov registry record · Phase 1
Topical Antibacterial Agents for Prevention of COVID-19
A Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 67
- Enrollment target
NCT05449392 is a Phase 1 study that has completed, run by Yale University. The registered enrollment target is 67 participants.
The verdict
NCT05449392, a Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 67 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine whether intranasal application of aminoglycoside (Neosporin) increases local nasal innate immune responses compared to placebo control in healthy participants.
Interventions
- OTHER Vaseline
- DRUG Neosporin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2023-09-22 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05449392
The ClinicalTrials.gov registry entry for NCT05449392 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vaseline is the first listed.
NCT05449392 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05449392 about?
NCT05449392 is a clinical study titled "Topical Antibacterial Agents for Prevention of COVID-19". The primary objective of this study is to determine whether intranasal application of aminoglycoside (Neosporin) increases local nasal innate immune responses compared to placebo control in healthy participants.
What is the current status of trial NCT05449392?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 67 participants. The study started on 2022-09-01. Estimated completion is 2023-09-22.
What interventions are being tested in trial NCT05449392?
The interventions under investigation include: Vaseline (OTHER), Neosporin (DRUG).
Who is sponsoring clinical trial NCT05449392?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.